Loading viewer...
investor_presentation
Format: PDF investor_presentation
Classified -Confidential The Coca- Cola Company 4th Quarter and Full Year 2016 Earnings Call February 9, 2017
Classified -Confidential
The Coca- Cola Company
4th Quarter and Full Year 2016 Earnings Call
February 9, 2017Agenda
Q&AClassified -Confidential 2016 Highlights
Segmented Market Roles and Disciplined Brand Investments
Over $600 Million in ProductivityStrong Top -Line Growth in the Core Business
Strengthened Our Brands and Portfolio
Introduced More Than 500 New Products into the MarketClassified -Confidential Strengthening Our Bottling System
~50% OF OUR BUSINESS IN MOTION*COMPLETED Q2 2017
*As measured by 2015 system revenueExpected
Close Q2 2017Better System Alignment, Synergies, Improved Customer and Consumer Attention
21stCentury Beverage
Partnership ModelCoca -Cola European
PartnersCoca -Cola Beverages
Africa2-Bottler Strategy for
Mainland ChinaMerger
East and WestNORTH AMERICA EUROPE AFRICA CHINA JAPAN
COMPLETED / 2017 BY YE 2017Operational
ReviewClassified -Confidential *Organic revenue (non -GAAP )
**Comparable currency neutral income before taxes (structurally adjusted) (non -GAAP) 6Fourth Quarter and Full Year 2016 Results
+8%+1% -1%Classified -Confidential 2016 Performance in Key Markets
We continue to push hard where we have momentum, take action where needed, and manage through difficult operating conditions
•Organic Revenue +4%*
•Top-Tier FMCG Growth
•Strong Marketing & Innovation
•New Product Launches•Strong Marketing & Innovation
•New Product Launches
•Improved Performance in
the Back Half of the Year•Solid Marketing & Innovation
Preview truncated — download the full document for the complete content.
annual_report
88 Pages
investor_presentation
33 Pages
EV Resources
Iovance Biotherapeutics Investor Presentation — November 2021
investor_presentationinvestor_presentation
34 Pages
Iovance Biotherapeutics, Inc